Literature DB >> 18689546

IL-7 and IL-15 differentially regulate CD8+ T-cell subsets during contraction of the immune response.

Mark P Rubinstein1, Nicholas A Lind, Jared F Purton, Pauline Filippou, J Adam Best, Patrick A McGhee, Charles D Surh, Ananda W Goldrath.   

Abstract

Although it is known that interleukin-7 (IL-7) and IL-15 influence the survival and turnover of CD8+ T cells, less is known about how these cytokines affect different subsets during the course of the immune response. We find that IL-7 and IL-15 differentially regulate CD8+ T-cell subsets defined by KLRG1 and CD127 expression during the contraction phase of the immune response. The provision of IL-15, or the related cytokine IL-2, during contraction led to the preferential accumulation of KLRG1(hi)CD127(lo) CD8+ T cells, whereas provision of IL-7 instead favored the accumulation of KLRG1(lo)CD127(hi) cells. While IL-7 and IL-15 both induced proliferation of KLRG1(lo) cells, KLRG1(hi) cells exhibited an extraordinarily high level of resistance to cytokine-driven proliferation in vivo despite their dramatic accumulation upon IL-15 administration. These results suggest that IL-15 and IL-2 greatly improve the survival of KLRG1(hi) CD8+ T cells, which are usually destined to perish during contraction, without inducing proliferation. As the availability of IL-15 and IL-2 is enhanced during periods of extended inflammation, our results suggest a mechanism in which a population of cytokine-dependent KLRG1(hi) CD8+ T cells is temporarily retained for improved immunity. Consideration of these findings may aid in the development of immunotherapeutic strategies against infectious disease and cancer.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18689546      PMCID: PMC2572798          DOI: 10.1182/blood-2008-06-160945

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  50 in total

Review 1.  Interleukin-2 and interleukin-15: immunotherapy for cancer.

Authors:  Todd A Fehniger; Megan A Cooper; Michael A Caligiuri
Journal:  Cytokine Growth Factor Rev       Date:  2002-04       Impact factor: 7.638

Review 2.  Cytokine control of memory T-cell development and survival.

Authors:  Kimberly S Schluns; Leo Lefrançois
Journal:  Nat Rev Immunol       Date:  2003-04       Impact factor: 53.106

3.  IL-15 augments CD8+ T cell-mediated immunity against Toxoplasma gondii infection in mice.

Authors:  I A Khan; L H Kasper
Journal:  J Immunol       Date:  1996-09-01       Impact factor: 5.422

4.  Multiple mechanisms compensate to enhance tumor-protective CD8(+) T cell response in the long-term despite poor CD8(+) T cell priming initially: comparison between an acute versus a chronic intracellular bacterium expressing a model antigen.

Authors:  Renu Dudani; Yvan Chapdelaine; Henk van Faassen Hv; Dean K Smith; Hao Shen; Lakshmi Krishnan; Subash Sad
Journal:  J Immunol       Date:  2002-06-01       Impact factor: 5.422

5.  Opposing effects of IL-2 in tumor immunotherapy: promoting CD8 T cell growth and inducing apoptosis.

Authors:  Protul Shrikant; Matthew F Mescher
Journal:  J Immunol       Date:  2002-08-15       Impact factor: 5.422

6.  Therapeutic use of IL-2 to enhance antiviral T-cell responses in vivo.

Authors:  Joseph N Blattman; Jason M Grayson; E John Wherry; Susan M Kaech; Kendall A Smith; Rafi Ahmed
Journal:  Nat Med       Date:  2003-04-14       Impact factor: 53.440

7.  Systemic administration of IL-15 augments the antigen-specific primary CD8+ T cell response following vaccination with peptide-pulsed dendritic cells.

Authors:  Mark P Rubinstein; Andre N Kadima; Mohamed L Salem; Christophe L Nguyen; William E Gillanders; David J Cole
Journal:  J Immunol       Date:  2002-11-01       Impact factor: 5.422

8.  Interleukin 15 is required for proliferative renewal of virus-specific memory CD8 T cells.

Authors:  Todd C Becker; E John Wherry; David Boone; Kaja Murali-Krishna; Rustom Antia; Averil Ma; Rafi Ahmed
Journal:  J Exp Med       Date:  2002-06-17       Impact factor: 14.307

9.  Cytokine requirements for acute and Basal homeostatic proliferation of naive and memory CD8+ T cells.

Authors:  Ananda W Goldrath; Pallavur V Sivakumar; Moira Glaccum; Mary K Kennedy; Michael J Bevan; Christophe Benoist; Diane Mathis; Eric A Butz
Journal:  J Exp Med       Date:  2002-06-17       Impact factor: 14.307

10.  Interleukin (IL)-15 and IL-7 jointly regulate homeostatic proliferation of memory phenotype CD8+ cells but are not required for memory phenotype CD4+ cells.

Authors:  Joyce T Tan; Bettina Ernst; William C Kieper; Eric LeRoy; Jonathan Sprent; Charles D Surh
Journal:  J Exp Med       Date:  2002-06-17       Impact factor: 14.307

View more
  100 in total

1.  Differential localization of effector and memory CD8 T cell subsets in lymphoid organs during acute viral infection.

Authors:  Yong Woo Jung; Rachel L Rutishauser; Nikhil S Joshi; Ann M Haberman; Susan M Kaech
Journal:  J Immunol       Date:  2010-10-04       Impact factor: 5.422

Review 2.  Once a killer, always a killer: from cytotoxic T cell to memory cell.

Authors:  Leo Lefrançois; Joshua J Obar
Journal:  Immunol Rev       Date:  2010-05       Impact factor: 12.988

3.  Differential effects of STAT5 and PI3K/AKT signaling on effector and memory CD8 T-cell survival.

Authors:  Timothy W Hand; Weiguo Cui; Yong Woo Jung; Esen Sefik; Nikhil S Joshi; Anmol Chandele; Ying Liu; Susan M Kaech
Journal:  Proc Natl Acad Sci U S A       Date:  2010-09-07       Impact factor: 11.205

Review 4.  Interleukin-2 receptor signaling: at the interface between tolerance and immunity.

Authors:  Thomas R Malek; Iris Castro
Journal:  Immunity       Date:  2010-08-27       Impact factor: 31.745

Review 5.  The persistence of T cell memory.

Authors:  Mark A Daniels; Emma Teixeiro
Journal:  Cell Mol Life Sci       Date:  2010-04-04       Impact factor: 9.261

Review 6.  Early events governing memory CD8+ T-cell differentiation.

Authors:  Joshua J Obar; Leo Lefrançois
Journal:  Int Immunol       Date:  2010-05-26       Impact factor: 4.823

7.  STAT5 is critical to maintain effector CD8+ T cell responses.

Authors:  Pulak Tripathi; Sema Kurtulus; Sara Wojciechowski; Allyson Sholl; Kasper Hoebe; Suzanne C Morris; Fred D Finkelman; H Leighton Grimes; David A Hildeman
Journal:  J Immunol       Date:  2010-07-19       Impact factor: 5.422

8.  Role of tumor suppressor TSC1 in regulating antigen-specific primary and memory CD8 T cell responses to bacterial infection.

Authors:  Sruti Krishna; Jialong Yang; Hongxia Wang; Yurong Qiu; Xiao-Ping Zhong
Journal:  Infect Immun       Date:  2014-05-12       Impact factor: 3.441

9.  Murine autoimmune cholangitis requires two hits: cytotoxic KLRG1(+) CD8 effector cells and defective T regulatory cells.

Authors:  Wenting Huang; Kritika Kachapati; David Adams; Yuehong Wu; Patrick S C Leung; Guo-Xiang Yang; Weici Zhang; Aftab A Ansari; Richard A Flavell; M Eric Gershwin; William M Ridgway
Journal:  J Autoimmun       Date:  2014-02-18       Impact factor: 7.094

10.  The Magnitude of IFN-γ Responses Is Fine-Tuned by DNA Architecture and the Non-coding Transcript of Ifng-as1.

Authors:  Franziska Petermann; Aleksandra Pękowska; Catrina A Johnson; Dragana Jankovic; Han-Yu Shih; Kan Jiang; William H Hudson; Stephen R Brooks; Hong-Wei Sun; Alejandro V Villarino; Chen Yao; Kentner Singleton; Rama S Akondy; Yuka Kanno; Alan Sher; Rafael Casellas; Rafi Ahmed; John J O'Shea
Journal:  Mol Cell       Date:  2019-07-31       Impact factor: 17.970

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.